These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29619991)

  • 1. Accelerated repigmentation of vitiligo after an irritant reaction following occlusion dressing with topical tacrolimus.
    Ju HJ; Lee JH; Kim GM; Park CJ; Bae JM
    Eur J Dermatol; 2018 Jun; 28(3):388-390. PubMed ID: 29619991
    [No Abstract]   [Full Text] [Related]  

  • 2. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
    Hartmann A; Bröcker EB; Hamm H
    J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.
    Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS
    J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tacrolimus for repigmentation of vitiligo.
    Grimes PE; Soriano T; Dytoc MT
    J Am Acad Dermatol; 2002 Nov; 47(5):789-91. PubMed ID: 12399778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo.
    Lo YH; Cheng GS; Huang CC; Chang WY; Wu CS
    J Dermatol; 2010 Feb; 37(2):125-9. PubMed ID: 20175845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the efficacy of microneedling combined with 5-fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo.
    Mina M; Elgarhy L; Al-Saeid H; Ibrahim Z
    J Cosmet Dermatol; 2018 Oct; 17(5):744-751. PubMed ID: 29532621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
    Hartmann A; Bröcker EB; Hamm H
    Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
    Majid I
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
    Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus-induced hyperpigmentation in a patch of vitiligo.
    De D; Kanwar AJ
    Skinmed; 2008; 7(2):93-4. PubMed ID: 18327009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal hypertrichosis during topical tacrolimus therapy for childhood vitiligo.
    Prats Caelles I; Herranz Pinto P; de Ayala Casado EL; de Lucas Laguna R
    Pediatr Dermatol; 2005; 22(1):86-7. PubMed ID: 15660910
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study.
    Nisticò S; Chiricozzi A; Saraceno R; Schipani C; Chimenti S
    Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus.
    Mikhail M; Wolchok J; Goldberg SM; Dunkel IJ; Roses DF; Silverberg NB
    Arch Dermatol; 2008 Apr; 144(4):560-1. PubMed ID: 18427063
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
    Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
    Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of fire needle therapy in treating non-segmental stable vitiligo: A randomized self-controlled clinical trial.
    Wang Y; Lin M; Huang F; Jia R; Xu W; He Q; Xiong Q; Hu Q; Diao Q; Liu Z
    J Cosmet Dermatol; 2024 Oct; 23(10):3335-3346. PubMed ID: 38894565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of tacrolimus ointment in the treatment of vitiligo.
    Du J; Wang XY; Ding XL; Xu QX; Chen Z; Chang JM; Zhang JZ
    J Dermatol; 2013 Nov; 40(11):935-6. PubMed ID: 24111918
    [No Abstract]   [Full Text] [Related]  

  • 17. Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo.
    Abd-Elazim NE; Yassa HA; Mahran AM
    J Cosmet Dermatol; 2020 Jun; 19(6):1447-1455. PubMed ID: 31668003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verruca vulgaris following treatment with tacrolimus ointment.
    Narang T; Pahwa M; Kanwar AJ; Parsad D
    Dermatology; 2006; 213(3):254-5. PubMed ID: 17033184
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical tacrolimus for treatment of childhood vitiligo in Asians.
    Kanwar AJ; Dogra S; Parsad D
    Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitiligo. Treatment of 12 cases with topical tacrolimus].
    Almeida P; Borrego L; Rodríguez-López J; Luján D; Cameselle D; Hernández B
    Actas Dermosifiliogr; 2005 Apr; 96(3):159-63. PubMed ID: 16476357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.